Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 4:14:1168927.
doi: 10.3389/fendo.2023.1168927. eCollection 2023.

Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy

Affiliations
Case Reports

Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy

Lingling Zhou et al. Front Endocrinol (Lausanne). .

Abstract

Background: Dysregulation of glucose metabolism has been linked to SARS-CoV-2 infection. In addition, the occurrence of new onset diabetes mellitus, including fulminant type 1 diabetes, has been reported after SARS-CoV-2 infection or vaccination.

Methods and results: A young Chinese woman in her last trimester of pregnancy presented with an abrupt progression of hyperglycemia and ketoacidosis, but with a near-normal glycohemoglobin level following paucisymptomatic SARS-CoV-2 infection. The low C peptide levels, both fasting and postprandial, reflected profound insulin deficiency in the setting of negative islet autoantibody testing, consistent with a diagnosis of fulminant type 1 diabetes. Ketoacidosis and hyperglycemia quickly improved following the introduction of insulin therapy, but not the β cell function. The patient received treatment with insulin pump therapy after being discharged, and the first follow-up revealed a well-controlled glucose profile.

Conclusions: New-onset FT1D can occur after SARS-CoV-2 infection. Our report raises awareness of this rare but serious situation, promoting early recognition and management of FT1D during the COVID-19 pandemic.

Keywords: case report; coronavirus disease 2019 (COVID- 19); fulminant type 1 diabetes; pregnancy; severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Timeline of events and important information of this patient.

Similar articles

Cited by

References

    1. Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after covid-19. Diabetologia (2022) 65(6):949–54. doi: 10.1007/s00125-022-05670-0 - DOI - PMC - PubMed
    1. Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, et al. . Did the covid-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care (2020) 43(11):e172–e3. doi: 10.2337/dc20-1633 - DOI - PMC - PubMed
    1. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka iddm study group. N Engl J Med (2000) 342(5):301–7. doi: 10.1056/NEJM200002033420501 - DOI - PubMed
    1. Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H, et al. . Report of the committee of the Japan diabetes society on the research of fulminant and acute-onset type 1 diabetes mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig (2012) 3(6):536–9. doi: 10.1111/jdi.12024 - DOI - PMC - PubMed
    1. Tang X, He B, Liu Z, Zhou Z, Li X. Fulminant type 1 diabetes after covid-19 vaccination. Diabetes Metab (2022) 48(2):101324. doi: 10.1016/j.diabet.2022.101324 - DOI - PMC - PubMed

Publication types